Predictors of residual disease after debulking surgery in advanced stage ovarian cancer.

Abbas-Aghababazadeh, Farnoosh; Sasamoto, Naoko; Townsend, Mary K; Huang, Tianyi; Terry, Kathryn L; Vitonis, Allison F; Elias, Kevin M; Poole, Elizabeth M; Hecht, Jonathan L; Tworoger, Shelley S; Fridley, Brooke L.

Afiliação

Abbas-Aghababazadeh F; Department of Biostatistics & Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
Sasamoto N; University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada.
Townsend MK; Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Huang T; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
Terry KL; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Vitonis AF; Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Elias KM; Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Poole EM; Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Hecht JL; Sanofi Genzyme, Global Medical Affairs, Cambridge, MA, United States.
Tworoger SS; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Fridley BL; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.